Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 09:51 am Sale | 2026-03-13 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 0 0.000% | -16,202,129![]() (Position Closed) | Filing History |
| 2026-03-19 6:35 pm Sale | 2026-03-17 | 13D | IRONWOOD PHARMACEUTICALS INC C IRWD | Sarissa Capital Management LP | 9,444,944 5.800% | -5,482,900![]() (-36.73%) | Filing History |
| 2026-02-17 9:45 pm Sale | 2025-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | ARMISTICE CAPITAL LLC | 16,025,000 9.850% | -125,000![]() (-0.77%) | Filing History |
| 2025-11-14 1:54 pm Purchase | 2025-09-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BANK OF AMERICA CORP BAC | 11,986,267 7.400% | 11,986,267![]() (New Position) | Filing History |
| 2025-11-12 3:34 pm Sale | 2025-09-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BARCLAYS PLC | 3,167,713 1.950% | -7,966,144![]() (-71.55%) | Filing History |
| 2025-08-15 12:26 pm Purchase | 2025-06-30 | 13G | CYCLO THERAPEUTICS INC CYTH | ARMISTICE CAPITAL LLC | 16,150,000 9.940% | 2,450,000![]() (+17.88%) | Filing History |
| 2025-08-12 5:58 pm Purchase | 2025-06-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BARCLAYS PLC | 11,133,857 6.880% | 11,133,857![]() (New Position) | Filing History |
| 2025-07-07 1:19 pm Purchase | 2025-06-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 16,202,129 10.010% | 505,968![]() (+3.22%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | ARMISTICE CAPITAL LLC | 13,700,000 8.470% | 4,232,000![]() (+44.70%) | Filing History |
| 2025-05-13 11:32 am Sale | 2025-03-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | STATE STREET CORP STT | 3,498,289 2.200% | -4,830,528![]() (-58.00%) | Filing History |
| 2025-05-02 11:13 am Sale | 2025-03-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Pacer Advisors Inc. | 1,789,098 1.120% | -9,941,673![]() (-84.75%) | Filing History |
| 2025-05-02 10:42 am Purchase | 2024-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | Pacer Advisors Inc. | 11,730,771 7.320% | 11,730,771![]() (New Position) | Filing History |
| 2025-04-30 11:22 am Sale | 2025-03-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 15,696,161 9.800% | -3,842,394![]() (-19.67%) | Filing History |
| 2025-03-07 12:19 pm Sale | 2025-02-28 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | BlackRock Inc. BLK | 11,284,399 7.100% | -11,633,925![]() (-50.76%) | Filing History |
| 2025-02-14 5:49 pm Purchase | 2024-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | ARMISTICE CAPITAL LLC | 9,468,000 5.920% | 1,268,000![]() (+15.46%) | Filing History |
| 2025-02-05 07:27 am Sale | 2024-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | STATE STREET CORP STT | 8,328,817 5.200% | -1,591,048![]() (-16.04%) | Filing History |
| 2025-01-31 11:44 am Sale | 2024-12-31 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 19,538,555 12.200% | -2,499,542![]() (-11.34%) | Filing History |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | ARMISTICE CAPITAL LLC | 8,200,000 5.130% | 8,200,000![]() (New Position) | Filing History |
| 2024-11-13 2:41 pm Purchase | 2024-05-15 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | RENAISSANCE TECHNOLOGIES LLC | 8,597,198 5.370% | 8,597,198![]() (New Position) | Filing History |
| 2024-11-12 3:47 pm Unchanged | 2024-09-30 | 13G | IRONWOOD PHARMACEUTICALS INC C IRWD | VANGUARD GROUP INC | 22,038,097 13.790% | 0 (Unchanged) | Filing History |

